#National Institutes of Health

AVAC’s theme for HVAD 2021 is “HIV Vaccine Research: Building on Lessons from COVID.”

Cancer, diabetes and Alzheimer’s would be the initial focus for the proposed agency within the National Institutes of Health.

Study findings may help explain why wearing masks has been linked to lower disease severity in people with COVID-19.

People who have had COVID-19 appear to be protected against reinfection for at least a few months.

NIAID director Anthony Fauci, MD, and coauthors emphasize the need for a global response to COVID-19.

But American Indians and Alaska Natives saw the sharpest increase in deaths involving methamphetamines. Here’s a possible solution.

But new data add to the evidence that mother-to-infant transmission of the coronavirus appears to be rare.

More than 95% of people who recovered from COVID-19 had durable immune system memory up to eight months after infection.

Full-dose anticoagulation treatment for moderately ill COVID-19 patients reduced the need for ventilators.

The ACTIV-2 study aims to determine whether neutralizing antibodies reduce the duration of COVID-19 symptoms.

Results from a study of 19 deceased patients suggests brain damage is a byproduct of a patient’s illness.

Preliminary results suggest anti-COVID19 nanobodies may be effective at preventing and diagnosing infections.

Anthony Fauci, President-elect Joe Biden and senior legislators were vaccinated publicly to demonstrate their confidence in vaccine safety.

Among 64 pregnant women who tested positive for SARS-CoV-2, none of their newborns tested positive.

Two Phase III clinical trials are evaluating monoclonal antibodies for people hospitalized with moderate COVID-19.

The study will evaluate short- and long-term health outcomes of COVID-19, including multisystem inflammatory syndrome.